L2P4 (TFA)
L2P4 TFA is a peptide-based and EBNA1 targeting fluorescent probe, which inhibits the EBNA1 homodimer formation and selectively inhibits EBV+ tumor growth. L2P4 TFA exhibits cytotoxicity in EBV-positive C666-1 cell with LC50 of 46.4 μM[1].
Product Specifications
UNSPSC
12352209
Target
EBV; Peptide-Drug Conjugates (PDCs)
Related Pathways
Antibody-drug Conjugate/ADC Related; Anti-infection
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
98.25
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H](CCSC)C(N[C@@H](C(C)C)C(N[C@@H](CC2=CC=CC=C2)C(NCC(NCC(N[C@@H](CCCNC(N)=N)C(N[C@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCCN)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@@H](NC(CCCCCNC([C@@H](NC(C[N+]3=CC=C(/C=C/C(C=C4)=CC=C4N(CC)CC)C=C3)=O)CS)=O)=O)CC5=CC=C(O)C=C5.OC(C(F)(F)F)=O.[Cl-].[x]
Molecular Formula
C93H138ClN25O16S2.xC2HF3O2
Molecular Weight
1961.83 (free base)
References & Citations
[1]Li X, et al., Biocompatible Porphyrin-Peptide Conjugates as Theranostic Agents Targeting the Epstein-Barr Virus. Chempluschem. 2022 Aug 10;87 (11) :e202200184.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15086117 1 Vial
Lentiviral human POU6F1 shRNA (UAS) - Lentiviral human POU6F1 shRNA (UAS) (25)
Sign In for Pricing
View Details 
